Taiki Isei

Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma

Naoya Yamazaki, Yoshio Kiyohara, Hisashi Uhara et al. · Cancer Science · 2017 · 124 citations · Full text

Cytokine Biomarkers, Immunology, Immunoediting +20

The wound/burn guidelines – 6: Guidelines for the management of burns

Yuichiro Yoshino, Mikio Ohtsuka, Masakazu Kawaguchi et al. · The Journal of Dermatology · 2016 · 75 citations · Full text

Treatment of acquired perforating dermatosis with narrowband ultraviolet B

Shuichi Ohe, Kiichiro Danno, Hiroko Sasaki et al. · Journal of the American Academy of Dermatology · 2004 · 50 citations

Narrowband Ultraviolet B, Clinical Dermatology, Wound Healing +3

Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study)

Yasuhiro Nakamura, Kenjiro Namikawa, Shusuke Yoshikawa et al. · ESMO Open · 2021 · 50 citations · Full text

Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter study

Yoshiyasu Umeda, Shusuke Yoshikawa, Yukiko Kiniwa et al. · European Journal of Cancer · 2021 · 39 citations

Cancer Immunosurveillance, Anti-ctla-4 Antibodies, Medicine +10